Nastech Pharmaceutical Company Inc. is an emerging pharmaceutical company focusing on development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology for delivering both small and large molecule drugs.

This offering has been priced at $13.50 per share.

Successful participants should be able to see the executed trade in their brokerage accounts on 12/09/04. To view the completed trade, log in to your WR Hambrecht + Co brokerage account.